Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tabirafusp Tedromer vs Aflibercept in Diabetic Macular Edema (ALTO)
NCT07734844Phase 3Recruiting
- Sponsor
- Kodiak Sciences
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 2
01
Overview
A Phase 3 trial of tabirafusp tedromer in diabetic macular edema (DME), sponsored by Kodiak Sciences. Started Aug 2026; status: recruiting.
02
Drugs
tabirafusp tedromer
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07734844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07734844.